Financial Personal
Helius Medical Technologies, Inc. Announces Pricing of $6.4 Million Public Offering
NEWTOWN, Pa., May 06, 2024 (GLOBE NEWSWIRE) — Helius Medical Technologies, Inc. (Nasdaq: HSDT) (“Helius” or the “Company”), a neurotech company focused on delivering a novel therapeutic neuromodulation approach for balance and gait deficits, to
The offering is expected to close on or about May 9, 2024, subject to customary closing conditions. The Company intends to use the net proceeds from this offering for funding operations, working capital and other general corporate purposes. Read More
